This Biotech Startup Just Raised $47 Million To Make Drugs From Fungi

In order to find the next penicillin, Menlo Park-based startup Hexagon Bio uses an AI platform to sequence the genomes of fungi.

Source: Forbes.com Healthcare News - September 15, 2020 Category: Pharmaceuticals Authors: Leah Rosenbaum, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Science /science Editors' Pick editors-pick Source Type: news